PMID- 15221046 OWN - NLM STAT- MEDLINE DCOM- 20040928 LR - 20061115 IS - 0037-5675 (Print) IS - 0037-5675 (Linking) VI - 45 IP - 7 DP - 2004 Jul TI - Emergency physician versus cardiologist-initiated thrombolysis for acute myocardial infarction: a Singapore experience. PG - 313-7 AB - INTRODUCTION: To compare the door-to-needle time between thrombolysis administration for patients with ST elevation myocardial infarction (STEMI) in the emergency department (EMD) by emergency physicians and those administered in the coronary care unit (CCU) by cardiologists. METHODS: The data was collected prospectively for all patients with STEMI who received thrombolysis in the emergency department over a one-year period from January 2001 to December 2001. We recorded the time of arrival in the EMD as well as the time thrombolytic therapy was commenced. This data was compared to those from the previous year, obtained retrospectively, where the patients received thrombolysis in the CCU. RESULTS: 118 patients were thrombolysed in the CCU and 78 patients were thrombolysed in the EMD. The median door-to-needle time was significantly shorter in patients who are thrombolysed in the emergency department by emergency physicians than in the coronary care unit by cardiologists (29 minutes versus 60 minutes, p value is less than 0.001). There was no incident of inappropriate thrombolysis nor was there intracranial or gastrointestinal bleed in the patients who were thrombolysed in the EMD. There was one case of medication dose error but it was of no consequence to the patient. CONCLUSION: Emergency physicians can administer thrombolytic treatment appropriately, quickly and safely in patients with STEMI. FAU - Irwani, I AU - Irwani I AD - Emergency Department, National University Hospital, 5 Lower Kent Ridge Road, Singapore 119074. irwani@nuh.com.sg FAU - Seet, C M AU - Seet CM FAU - Manning, P G AU - Manning PG LA - eng PT - Comparative Study PT - Journal Article PL - India TA - Singapore Med J JT - Singapore medical journal JID - 0404516 RN - 0 (Fibrinolytic Agents) RN - EC 3.4.- (Streptokinase) RN - EC 3.4.21.68 (Tissue Plasminogen Activator) SB - IM MH - Adult MH - Aged MH - Aged, 80 and over MH - Coronary Care Units/*statistics & numerical data MH - Electrocardiography MH - Emergency Service, Hospital/*statistics & numerical data MH - Female MH - Fibrinolytic Agents/*administration & dosage/adverse effects MH - Humans MH - Male MH - Middle Aged MH - Myocardial Infarction/diagnosis/*drug therapy MH - Physicians MH - Prospective Studies MH - Retrospective Studies MH - Singapore/epidemiology MH - Streptokinase/administration & dosage/adverse effects MH - Thrombolytic Therapy/adverse effects/*statistics & numerical data MH - Time Factors MH - Tissue Plasminogen Activator/administration & dosage/adverse effects EDAT- 2004/06/29 05:00 MHDA- 2004/09/29 05:00 CRDT- 2004/06/29 05:00 PHST- 2004/06/29 05:00 [pubmed] PHST- 2004/09/29 05:00 [medline] PHST- 2004/06/29 05:00 [entrez] PST - ppublish SO - Singapore Med J. 2004 Jul;45(7):313-7.